MK-2866 vs MK-677 for performance
Short answer: For performance, users rate them about the same: 87% report improvement with MK-2866 (252 reports) and 90% with MK-677 (87 reports).
MK-2866 has 0 meta-analyses and 0 randomized trials on PubMed; MK-677 has 0 and 15.
Based on 789 reports about MK-2866 and 978 about MK-677. Not medical advice.
| MK-2866 SARM | MK-677 Substance | |
|---|---|---|
| Users say it helped | 37%helped489 reports · high confidence | 39%helped479 reports · high confidence |
| Verdict | Mixed | Mixed |
| Research | DResearch: None | BResearch: Moderate |
| Meta-analyses / RCTs | 0 / 0 | 0 / 15 |
| Mainly used for | ||
| Performance % reporting improvement | 87% (252) | 90% (87) |
| Appetite % reporting improvement | 56% (9) | 66% (228) |
| Sleep % reporting improvement | 16% (25) | 79% (170) |
| Recovery % reporting improvement | 96% (78) | 99% (106) |
| Weight loss % reporting improvement | 88% (100) | 53% (55) |
| Common side effects | suppression, fatigue, insomnia, headache | water retention, fatigue, stomach issues, hunger |
| Typical dose reported | Not listed | 12.5 mg / before dinner |
MK-2866Full MK-2866 profile →
What a user said
“I've taken LDG-4033 and Ostarine from Ceretropic and noticed slight psychoactive effects from both, immediately (within 30 minutes after dosing).”
MK-677Full MK-677 profile →
What a user said
“From my own experience (also have suffered from poor sleep), i experienced a noticeable increase in sleep quality even with a low dose.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate